Tyrosine Kinase Inhibitors as a Treatment of Symptomatic CNS Metastases in Oncogene-Driven NSCLC

Central nervous system (CNS) metastases occur frequently in oncogene-driven non-small cell lung cancer (NSCLC). Standard treatment approaches can potentially delay systemic treatment (surgical intervention) or result in neurocognitive impairment (radiotherapy). Recently, next-generation tyrosine kin...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Oncol
Main Authors: Gal, Omer, Dudnik, Elizabeth, Rotem, Ofer, Finkel, Inbar, Peretz, Idit, Zer, Alona, Mandel, Jacob, Amiel, Alexandra, Siegal, Tali, Bar, Jair, Lobachov, Anastasiya, Yust, Shlomit
Format: Artigo
Jezik:Inglês
Izdano: Hindawi 2020
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7486631/
https://ncbi.nlm.nih.gov/pubmed/32963526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/1980891
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki